AbbVie Inc. Business Finance Contracts & Agreements

71 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AbbVie Inc. Supplemental Indenture No. 11 for $4 Billion Senior Notes (2028–2055) with U.S. Bank Trust Company
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2025
AbbVie Inc. Underwriting Agreement for $4 Billion Senior Notes Offering (2028–2055)
Underwriting Agreements
AbbVie Inc.
Biotechnology
NY
2025
Description of AbbVie Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
NY
2025
AbbVie Inc. 5.500% Senior Notes due 2064 (Form of Global Note)
Note Agreements
AbbVie Inc.
Biotechnology
2024
AbbVie Inc. 5.400% Senior Notes due 2054 (Form of Global Note)
Note Agreements
AbbVie Inc.
Biotechnology
2024
AbbVie Inc. 5.350% Senior Notes due 2044 (Form of Global Security)
Note Agreements
AbbVie Inc.
Biotechnology
2024
AbbVie Inc. 5.050% Senior Notes Due 2034 (Form of Global Note)
Note Agreements
AbbVie Inc.
Biotechnology
2024
AbbVie Inc. 4.950% Senior Notes due 2031 (Form of Global Note)
Note Agreements
AbbVie Inc.
Biotechnology
2024
AbbVie Inc. 4.800% Senior Notes due 2029 (Form of Global Note)
Note Agreements
AbbVie Inc.
Biotechnology
2024
AbbVie Inc. 4.800% Senior Notes due 2027 (Form of Global Note)
Note Agreements
AbbVie Inc.
Biotechnology
2024
AbbVie Inc. Supplemental Indenture No. 10 for Senior Notes Due 2027–2064 with U.S. Bank Trust Company
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2024
AbbVie Inc. Underwriting Agreement for Senior Notes Offering (2024)
Underwriting Agreements
AbbVie Inc.
Biotechnology
NY
2024
Description of AbbVie Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
NY
2024
Second Amended and Restated $5,000,000,000 Revolving Credit Agreement among AbbVie Inc., Various Lenders, and JPMorgan Chase Bank, N.A.
Credit Agreements
AbbVie Inc.
Biotechnology
DE
2023
AbbVie Inc. Non-Qualified Stock Option Agreement with Employee
Stock Agreements
AbbVie Inc.
Biotechnology
IL
2022
AbbVie Inc. Non-Employee Director Restricted Stock Unit Agreement
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
IL
2022
Description of AbbVie Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
NY
2022
AbbVie Inc. Non-Qualified Stock Option Agreement with Employee (2021)
Warrant Agreements
AbbVie Inc.
Biotechnology
IL
2021
AbbVie Inc. Non-Employee Director Restricted Stock Unit Agreement (2021)
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
IL
2021
Description of AbbVie Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
NY
2021
Registration Rights Agreement between AbbVie Inc. and Dealer Managers for Exchange of Allergan Notes (May 14, 2020)
Registration Rights Agreements
AbbVie Inc.
Biotechnology
NY
2020
AbbVie Inc. Supplemental Indenture No. 9 for Senior Notes Due 2020–2029
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2020
AbbVie Inc. Supplemental Indenture No. 8 with U.S. Bank National Association (May 14, 2020)
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2020
AbbVie Inc. Restricted Stock Unit Agreement with Employee (2020)
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
IL
2020
AbbVie Inc. Non-Qualified Stock Option Agreement (2020) with Employee
Stock Agreements
AbbVie Inc.
Biotechnology
IL
2020
Amendment to Transaction Agreement among AbbVie Inc., Venice Subsidiary LLC, and Allergan plc (May 5, 2020)
Modification Agreements
AbbVie Inc.
Biotechnology
DE
2020
Description of AbbVie Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
NY
2020
AbbVie Inc. Supplemental Indenture No. 6 for €750,000,000 0.750% Senior Notes Due 2027 and €650,000,000 1.250% Senior Notes Due 2031
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2019
AbbVie Inc. Underwriting Agreement for €750,000,000 0.750% Senior Notes due 2027 and €650,000,000 1.250% Senior Notes due 2031
Underwriting Agreements
AbbVie Inc.
Biotechnology
IL
2019
Amended and Restated $4 Billion Revolving Credit Agreement among AbbVie Inc., Lenders, and JPMorgan Chase Bank, N.A.
Credit Agreements
AbbVie Inc.
Biotechnology
DE
2019
First Amendment to Revolving Credit Agreement among AbbVie Inc., Lenders, and JPMorgan Chase Bank, N.A.
Credit Agreements
AbbVie Inc.
Biotechnology
NY
2019
$6,000,000,000 Term Loan Credit Agreement among AbbVie Inc., Various Lenders, and Morgan Stanley Senior Funding, Inc. (July 12, 2019)
Credit Agreements
AbbVie Inc.
Biotechnology
DE
2019
$38,000,000,000 364-Day Bridge Credit Agreement among AbbVie Inc., Various Lenders, and Morgan Stanley Senior Funding, Inc.
Credit Agreements
AbbVie Inc.
Biotechnology
DE
2019
AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement (2019)
Stock Agreements
AbbVie Inc.
Biotechnology
DE
2019
AbbVie Inc. 2019 Non-Qualified Stock Option Agreement with Employee
Warrant Agreements
AbbVie Inc.
Biotechnology
DE
2019
AbbVie Inc. Non-Employee Director Restricted Stock Unit Agreement (2019)
Equity Distribution Agreements
AbbVie Inc.
Biotechnology
DE
2019
AbbVie Inc. Supplemental Indenture No. 5 for Senior Notes Due 2021, 2023, 2028, and 2048
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2018
Agency Agreement for Notes Issuance between AbbVie Inc. and U.S. Bank/Elavon Financial Services (May 14, 2020)
Trust Agreements
AbbVie Inc.
Biotechnology
IL
2020
AbbVie Inc. $30 Billion Senior Notes Purchase Agreement with Initial Purchasers (November 2019)
Purchase Agreements
AbbVie Inc.
Biotechnology
NY
2019
Agency Agreement for 0.750% Senior Notes Due 2027 and 1.250% Senior Notes Due 2031 – AbbVie Inc. and U.S. Bank Entities
Trust Agreements
AbbVie Inc.
Biotechnology
NY
2019